Cerebral And Tissue Oximetry Devices Market Size to grow by USD 96.3 million between 2024-2028
According to a research report “ Cerebral And Tissue Oximetry Devices Market” by Product (Modular devices, Handheld devices) End-user (Hospitals, Clinics) Geography (North America, Europe, Asia, Rest of World (ROW))- Global Forecast to 2028 published by Technavio, the market size is estimated to grow by USD 96.3 million, at a CAGR of 8.08% during the forecast period. In light of the rising incidence of cardiovascular diseases (CVDs), including cerebrovascular diseases, cardiomyopathy, and rheumatic heart diseases, the necessity for effective treatment in healthcare settings has become increasingly imperative. Many CVD therapies necessitate invasive surgical interventions, leading to a surge in patients seeking cardiac surgeries. However, these procedures carry the risk of adverse neurological events during the perioperative period. Anesthesia administered during cardiac surgeries can result in cerebral hypoxia or oxygen deprivation. To mitigate this risk, maintaining optimal oxygen delivery to tissues and organs, particularly the brain, is crucial. Advanced blood oxygenation monitoring devices, such as cerebral and tissue oximetry systems, are gaining significant traction in response to these requirements. These devices enable real-time monitoring of oxygen saturation levels, ensuring adequate oxygenation during surgical procedures and ultimately improving patient outcomes.
Browse market data tables, figures, and in-depth TOC on “Cerebral And Tissue Oximetry Devices Market” by Product (Modular devices, Handheld devices) End-user (Hospitals, Clinics) Geography (North America, Europe, Asia, Rest of World (ROW)) Global Forecast to 2028. Download Free Sample
By Product, the Modular devices segment is projected to dominate the market size in 2024
In the global cerebral and tissue oximetry devices market, hospitals represent the primary consumer base, significantly driving market expansion. Large and medium-sized hospitals, which typically operate under government sponsorship or private entities, prioritize enhancing their healthcare services by acquiring advanced cerebral and tissue oximetry devices. These hospitals, with over 500 hospital beds, cater to local and neighboring populations. In contrast, smaller hospitals face budgetary constraints, leading them to forgo high-end devices such as magnetic resonance imaging (MRI) systems. The focus on providing comprehensive healthcare services in large hospitals continues to fuel the demand for sophisticated cerebral and tissue oximetry devices.
By End-user, Hospitals segment is expected to hold the largest market size for the year 2024
Handheld cerebral and tissue oximetry devices represent the latest innovation in non-invasive patient monitoring solutions. These compact devices enable instant measurement of oxygen levels in blood without the need for patient contact or external connections to sensors or monitors. Advanced vendors offer compatibility features with their modular devices, creating a comprehensive monitoring solution for medical professionals during pre-operative, intra-operative, and post-operative assessments and surveillance. The integrated display screens of these devices provide real-time output values, ensuring efficient patient care and safeguarding.
North America is forecasted to hold the largest market size by region in 2024
The Cerebral and Tissue Oximetry Devices Market signifies a significant growth trajectory, driven by the increasing prevalence of neurological disorders and the rising demand for non-invasive diagnostic tools. These devices offer real-time monitoring of oxygen saturation levels in the brain and tissues, enabling early detection and effective treatment interventions. Market players focus on innovation and technological advancements to cater to this burgeoning demand.
The Cerebral And Tissue Oximetry Devices Market growth and forecasting report also includes detailed analyses of the competitive landscape of the market growth and forecasting and information about 20 market companies, including:
.
For insights on company offerings- Request a sample report!
Research Analysis Overview
The Cerebral And Tissue Oximetry Devices Market is witnessing significant growth due to the increasing demand for non-invasive monitoring of cerebral oxygenation levels in various medical specialties. These devices use a fiber-optic light source and a light detector to measure oxygen saturation in cerebral tissues through an oximeter probe placed on the forehead area. The cable connects the probe to the cerebral oximeter monitor, which displays the real-time data. Physicians in neurology, anesthesiology, and critical care use these devices to monitor cerebral oxygenation levels in patients with neurological conditions, chronic diseases, and during surgeries. The latest trends in this market include wireless connectivity, AI integration, and reimbursement policies to offset the high device costs. These devices are used in outpatient settings, operating rooms, ICUs, research settings, and during surgeries for premature infants and neonatal care. Sensors are also being developed for monitoring oxygen saturation in muscles and other tissues, including the liver. The market for cerebral and tissue oximetry devices is expected to grow significantly in the coming years due to the increasing demand for non-invasive monitoring in various medical applications.
Market Research Overview
The Cerebral and Tissue Oximetry Devices Market encompasses technologies that measure oxygen levels in the brain and other tissues. These devices are increasingly being used to monitor patients with neurodegenerative diseases, particularly in the geriatric population. The use of fiber-optic light sources and light detectors in oximeter probes placed on the forehead area or directly on the cerebral tissues enables the measurement of cerebral oxygenation levels. Physicians and healthcare professionals use these devices in various medical specialties, including cardiovascular diseases such as peripheral artery disease, cardiac surgeries, and heart disease. Portable and minimally invasive cerebral oximeter monitors offer real-time data analysis capabilities, making them suitable for outpatient settings and home healthcare. Reimbursement policies and high device costs remain challenges. Sensors for monitoring tissue oxygen levels are also used in research settings, ICUs, and surgeries for various organs like the liver and muscles. Advancements include wireless connectivity, AI integration, and user-friendly designs for end-users in hospitals and operating rooms. Non-invasive monitoring technologies offer flexibility and portability, with handheld devices and tabletop systems providing functionalities for surgeons and data analytics for medical specialties. Sensor technologies are also used in neonatal care for premature infants.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
